Tahlil

Etosüksimid (Petimitit)

Sanal Hastane||1 dk okuma
Etosüksimid  (Petimitit)

Klinik kullanımı :

Petit mal epilepsilerin tedavisinde kullanılan ilaçlardan biridir. İlaç

tedavisinin izlenmesi ve toksisite olasılığının değerlendirilmesi

amacıyla kullanılır.

Referans aralığı

Tedavi dozu :40-100 μg/ml

Toksik dozu :>150 μg/ml

Kaynaklar ve Referanslar

  1. [1]Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.”. The New England journal of medicine. 2010. PMID: 20200383. PubMed →
  2. [2]Mattson RH. Efficacy and adverse effects of established and new antiepileptic drugs.”. Epilepsia. 1995. PMID: 8784211. PubMed →
  3. [3]Ichiba M, Kitazawa S. [Ethosuximide].”. Nihon rinsho. Japanese journal of clinical medicine. 1995. PMID: 8753586. PubMed →
  4. [4]Faingold CL, Browning RA. Mechanisms of anticonvulsant drug action. II. Drugs primarily used for absence epilepsy.”. European Journal of Pediatrics. 1987. PMID: 3107994. PubMed →
  5. [5]Miyasaka N. Drug-induced lupus.”. Internal medicine (Tokyo, Japan). 1996. PMID: 8842756. PubMed →
  6. [6]Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy.”. Neurology. 2018. PMID: 29898971. PubMed →
Paylaş: